Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51

TECH CULTURES: Politecnico di Torino opens a call for expression of interest for guest curators in the Biennale Tecnologia 2026 festival 6-12-2024, 22:46

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis 7-11-2024, 18:00